Found: Written evidence submitted by L Grieve, Policy & Engagement Manager, British Pregnancy Advisory Service
Mar. 05 2012
Source Page: Dear Colleague letter dated 23/02/2012 from Dame Sally C Davies, Chief Medical Officer regarding Abortion Act 1967 (as amended): termination of pregnancy. 2 p.Found: Dame Sally C Davies, Chief Medical Officer regarding Abortion Act 1967 (as amended): termination of pregnancy
Found: Debate on hormone pregnancy tests
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 April 2021 to Question 185893 on Pregnancy: Screening, on what date the evaluative rollout of non-invasive prenatal testing is expected to be completed.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
A non-invasive pre-natal test (NIPT) was introduced as an evaluative rollout in England on 1 July 2021, as part of the NHS Fetal Anomaly Screening Programme. The UK National Screening Committee (UK NSC) is being kept informed annually on the progress of this rollout.
NHS England has extended the evaluative rollout of the NIPT to March 2026, so that pregnancy outcomes can be included in the final report. The report is expected to go to the UK NSC at the end of 2026.
Jun. 10 2008
Source Page: The Child Health Promotion Programme: pregnancy and the first five years of life. 80 p.Found: The Child Health Promotion Programme: pregnancy and the first five years of life. 80 p.
Mar. 12 2010
Source Page: Copy of article "Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraception Use", American Journal of Public Health, January 2007, vol. 97, No. 1. 7 p.Found: Copy of article "Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to encourage pregnant women to undertake smoking cessation programmes.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Smoking is the number one entirely preventable cause of ill-health, disability, and death in this country. It is responsible for 80,000 yearly deaths in the United Kingdom, and one in four of all UK cancer deaths. Smoking in pregnancy increases the risk of stillbirth, miscarriage, and sudden infant death.
As set out in Stopping the Start: our new plan to create a smokefree generation, we are establishing a financially incentivised scheme to help pregnant smokers and their partners to quit smoking, with smoking cessation support. This evidence-based intervention will encourage pregnant women to give up smoking, and remain smokefree throughout pregnancy and beyond, helping to improve the health and wellbeing of both mother and baby.
The objective is to have all maternity trusts that wish to participate in the scheme signed up by the end of 2024, so that all pregnant women who smoke in participating areas will be offered the opportunity to join the incentive scheme by December 2024.
This financial incentive scheme builds upon the NHS Long Term Plan’s ambition to ensure that all pregnant smokers can access behavioural support to quit from within maternity services, as well as additional funding for mass marketing campaigns on stopping smoking.
Written Evidence Oct. 19 2023
Inquiry: Women's reproductive healthFound: WRH0036 - Women's reproductive health British Pregnancy Advisory Service (BPAS) Written Evidence
Asked by: Cat Smith (Labour - Lancaster and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 17 January 2024 on Women’s Health Strategy update, HCWS192, whether the National Institute for Health and Care Research challenge fund will fund research into anti-epilepsy medicines safe for use in pregnancy.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department commissions research through the National Institute for Health and Care Research (NIHR). In the Written Statement of 17 January 2024, the NIHR announced plans for a £50 million NIHR Challenge to tackle disparities within maternity. This initiative is a new five-year investment allocated from within NIHR’s research budget. This funding is additional to the £53 million that the NIHR spent between April 2022 and July 2023 into research programmes to support women’s sexual and reproductive health, with further funding for wider health and care research that benefits women.
The specific focus of this work is being developed and we expect that the NIHR will launch a call for applications in spring 2024. Further information will be available on the NIHR website in due course. The NIHR welcomes funding applications for research into any aspect of human health, including anti-epilepsy medicines safe for use in pregnancy.
Oct. 04 2023
Source Page: Certification of pregnancy and baby loss prior to 24 weeks: leafletFound: Certification of pregnancy and baby loss prior to 24 weeks: leaflet